InvestorsHub Logo
Followers 13
Posts 3218
Boards Moderated 0
Alias Born 04/26/2007

Re: None

Wednesday, 01/12/2022 1:45:58 PM

Wednesday, January 12, 2022 1:45:58 PM

Post# of 40492
1/6/22 Update: INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

MGMT Methylated Median OS not yet reached. To gather OS36 for FDA Compassionate Use:

Primary Completion: December, 2021 => June 30, 2022 [Anticipated]
Study Completion: December 2021 => June 30, 2022 [Anticipated]
https://clinicaltrials.gov/ct2/history/NCT03491683?A=31&B=32&C=merged#StudyPageTop
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News